Evidence map›Paper›PMID 16636148›Full record

ArticleThe Journal of cell biology2006

A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin.

Pedro F Esteban, Hye-Young Yoon, Jodi Becker, Susan G Dorsey, Paola Caprari, Mary Ellen Palko, Vincenzo Coppola, H Uri Saragovi, Paul A Randazzo, Lino Tessarollo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Physiological and Pathological Roles of the Cytohesin Family in Neurons.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. NTRK fusion-positive cancers and TRK inhibitor therapy.Nature reviews. Clinical oncology · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pedro F EstebanNeural Development Group, Mouse Cancer Genetics Program, National Cancer Institute, Frederick, MD 21702, USA.
Hye-Young Yoon
Jodi Becker
Susan G Dorsey
Paola Caprari
Mary Ellen Palko
Vincenzo Coppola
H Uri Saragovi
Paul A Randazzo
Lino Tessarollo
National Cancer Institute · USCancer Genetics (United States) · USMcGill University · CA

Funding

REGULATION OF ADP-RIBOSYLATION FACTORZ01BC007365 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RANDAZZO, PAUL A · 1996 to 2008
$3.3M
Role of Neurotrophins in the Development of the Mammalian Nervous SystemZ01BC010390 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2000 to 2008
$1.7M
DESIGN AND SYNTHESIS OF FUNCTIONAL NGF PEPTIDOMIMETICSR01CA082642 · NCI · TEXAS A&M UNIVERSITY SYSTEM · PI BURGESS, KEVIN · 1999 to 2003
$1.1M
Role of Trk Receptors in the Development and Function of Non-neuronal StructuresZ01BC010391 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2000 to 2008
$1.1M
Intramural NIH HHSNCI NIH HHS CA82642NCI NIH HHS R01 CA082642
6 · The paper itself

Abstract

Neurotrophins play an essential role in mammalian development. Most of their functions have been attributed to activation of the kinase-active Trk receptors and the p75 neurotrophin receptor. Truncated Trk receptor isoforms lacking the kinase domain are abundantly expressed during development and in the adult; however, their function and signaling capacity is largely unknown. We show that the neurotrophin-3 (NT3) TrkCT1-truncated receptor binds to the scaffold protein tamalin in a ligand-dependent manner. Moreover, NT3 initiation of this complex leads to activation of the Rac1 GTPase through adenosine diphosphate-ribosylation factor 6 (Arf6). At the cellular level, NT3 binding to TrkCT1-tamalin induces Arf6 translocation to the membrane, which in turn causes membrane ruffling and the formation of cellular protrusions. Thus, our data identify a new signaling pathway elicited by the kinase-deficient TrkCT1 receptor. Moreover, we establish NT3 as an upstream regulator of Arf6.

Indexed as

Signal TransductionADP-Ribosylation Factor 6ADP-Ribosylation FactorsCarrier ProteinsCell LineCells, CulturedHumansMembrane ProteinsModels, BiologicalProtein Isoformsrac1 GTP-Binding ProteinReceptor, trkCADP-Ribosylation Factor 6ADP-Ribosylation FactorsARF6 protein, humanArf6 protein, mouseCarrier ProteinsMembrane ProteinsProtein Isoformsrac1 GTP-Binding ProteinReceptor, trkCtamalin protein, human

Identifiers

PMID16636148
PMCPMC2063819
OpenAlexW2159681451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.